Current filters:  
Healthcare
Canada
Miller Thomson LLP
In 2017, the then Ontario Ministry of Health and Long-Term Care issued a Hospital Naming Directive ("Naming Directive") setting out naming criteria and approval processes that all Ontario...
China
DeHeng Law Offices
面对新型冠状病毒汹涌来袭,...
DeHeng Law Offices
随着新型冠状病毒肺炎疫情(以下简称"肺炎疫情")...
India
Singh & Associates
On January 16, 2020, Indian Council of Medical Research announced a significant development that the WHO Global TB Programme has included an Indian Molecular assay...
Singh & Associates
Ayurveda, Yoga, Unani, Siddha and Homeopathy (AYUSH) - the traditional systems of medicine play a crucial role in public health in India.
Singh & Associates
On January 13, 2020, the Indian Council of Medical Research (ICMR) reported ‘Lead exposure' as a possible risk factor for causing Alzheimer's disease based on a study conducted at National...
Singh & Associates
Antimicrobial resistance (AMR) is a broad term for resistance in different types of microorganisms such as bacteria, viruses, fungi and parasites, to antibiotics such as...
Singh & Associates
The Central Drugs Standard Control Organization (CDSCO), New Delhi, under the aegis of the Ministry of Health ...
Mexico
OLIVARES
A decree was recently published modifying several provisions of the Health Law Regulations addressing the approval of biologic drugs.
UK
DAC Beachcroft LLP
The reports of these sandboxing exercises are expected later this year.
DLA Piper
On Thursday 30 January 2020, the World Health Organisation (WHO) declared a "Public Health Emergency of International Concern" following the outbreak, and rapid spread, of the 2019 novel...
United States
Sheppard Mullin Richter & Hampton
The language of the FAR reflects an intent not to require "substantial transformation" for analysis under the FAR; "manufacture" does not require substantial transformation.
Reed Smith
Given the quantities of drugs that these programs purchase, and the age of the regulation, we'd call this a big deal.
Foley & Lardner
For the second year in a row, Foley & Lardner LLP and PYA hosted a compliance master class on various health-related compliance issues. "Let's Talk Compliance"
Sheppard Mullin Richter & Hampton
January 30th, 2020 marked a dramatic change in Medicaid funding, as the Trump Administration and Centers for Medicare & Medicaid Services ("CMS") showcased a plan...
Reed Smith
Mention the Third Restatement of Torts and the learned intermediary rule in the same sentence, and our response would be to cite §6(d) of the product liability part of the Restatement
Sheppard Mullin Richter & Hampton
Joining host Michael Cohen to explore the evolving regulations surrounding the food industry are two guests, Michael Roberts and Sascha Henry.
Seyfarth Shaw LLP
Recently, the Trump Administration issued its proposed Notice of Benefit & Payment Parameter for 2021 regulations.
McDermott Will & Emery
On October 11, 2017, the Alcohol and Tobacco Tax and Trade Bureau (TTB) reopened the comment period for the following three notices of proposed rulemaking
Holland & Knight
The CMS released a SMD letter and fact sheet on Jan. 30, 2020, that encouraged states to pursue block grant or per capita cap funding through their Medicaid programs as part of the new Healthy Adult Opportunity.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media